Overview of Methodologies Addressing Transfusion-Associated Graft-Versus-Host Disease:
Irradiation and Pathogen Reduction - On Demand
When viable T-lymphocytes in transfused blood products engraft and multiply in the tissues of a recipient, they can react against the tissues of the recipient; this is called Transfusion-Associated Graft-Versus-Host Disease (TA-GVHD). Irradiation has been the standard to date for reducing the level of contaminating T-Cells to potentially decrease the risk of transfusion TA-GVHD. In addition to irradiation, AABB recognizes that contaminating T-cell activity is also reduced by the psoralen/UVA light treatment method of pathogen reduction, potentially lowering the risk of transfusion-associated graft versus host disease (TA-GVHD). This learning activity will compare these two methodologies for potential reduction of the risk of TA-GVHD.
- Describe the underlying cause and approaches for addressing Transfusion-Associated Graft-Versus-Host Disease (TA-GVHD).
- Discuss the AABB Standards for Blood Banks and Transfusion Services (BBTS) that address approaches for lowering the risk of or preventing TA-GVHD.
- Understand the two options authorized by the AABB Standards for prevention of TA-GVHD: irradiation and psoralen/UVA light treatment (pathogen reduction) of platelets.
Level of Instruction
Author / Speaker
Karen Giordano, MS, MT (ASCP) SBB - Senior Medical Science Liaison, Cerus Corporation
Karen Giordano is the Director of the Medical Science Liaison Program and a member of the Development Team at Cerus Corporation where she is focused on medical education for clinicians on topics around blood safety, transfusion medicine, and provides support for ongoing clinical trials. Karen has a long career in medical affairs and clinical research in transfusion medicine, hemostasis, coagulation, critical care, trauma and hematology. Her educational background includes an MS in biomedical chemistry from Thomas Jefferson University in Philadelphia and a BS in medical technology from Wesley College, as well as licensure as a clinical laboratory scientist and a specialist in blood bank (SBB).
Cerus Corporation is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.
Contact Hour: 1.0
Expires on: Mar 29, 2021 at 12:00 am CT the day of
Blitz + Associates, Inc. is approved by the California Board of Registered Nursing, provider number 15148 for 1.0 contact hours.
Contact Hour: 1.0
Expires on: Jun 2, 2020 at 12:00 am CT the day of
This program Has Been Approved by the American Association of Critical-Care Nurses (AACN) for 1.00 CERP, Synergy CERP Category A, File Number 22721.
Expires on: Jun 2, 2022 at 12:00 am CT the day of
Technical Requirements and Assistance
Minimum software requirements:
- Windows XP SP2
- Mac OS X 10.9
- iOS 7
- Android 4
- Learning activities may be in the Adobe Flash format. The latest version of Adobe Flash is always recommended to view this type of activity.
- Learning activities may be encoded as MP4 videos. Your browser must support MP4 playback natively or through the operating system to view these videos.
Minimum hardware requirements:
- 512MB of RAM
- 200MB of hard drive space
- Intel x86 processor
- Device capable of running iOS 7
- Device capable of running Android 4
Minimum connection speed:
- A broadband connection is required for Adobe Flash and MP4 learning activities.